Abstract:We report the synthesis and evaluation of a series of cell-permeable and N- versus O-selective sialyltransferase inhibitors. Inhibitor design entailed the functionalization of lithocholic acid at C(3) and at the cyclopentane ring side chain. Among the series, FCW34 and FCW66 were shown to inhibit MDA-MB-231 cell migration as effectively as ST3GALIII-gene knockdown did. FCW34 was shown to inhibit tumor growth, reduce angiogenesis, and delay cancer cell metastasis in animal models. Furthermore, FCW34 inhibited vessel development and suppressed angiogenic activity in transgenic zebrafish models. Our results provide clear evidence that FCW34-induced sialyltransferase inhibition reduces cancer cell metastasis by decreasing N-glycan sialylation, thus altering the regulation of talin/integrin/FAK/paxillin and integrin/NFκB signaling pathways.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01477?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01477</a>.Effect of 2aA–2eA on migration in MDA-MB-231 cells; effect of FCW34 on migration in MDA-MB-231 cells; effect of FCW66 on migration in MDA-MB-231 cells; effects of ST3GALIII siRNA knockdown efficiency in MDA-MB-231 cells; inhibition of integrin sialylation by sialyltransferase inhibitors in MDA-MB-231 cells; effects of sialyltransferase inhibitor FCW34 on tumor metastasis in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitor FCW34 on toxicity assessment in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitors on the integrin–FAK–paxillin pathway in MDA-MB-231 cells; effects of sialyltransferase inhibitors on the NFκB pathway in MDA-MB-231 cells; apparent permeability (Papp) values obtained for the reference compounds, FCW34, and FCW66 using the PAMPA model; endogenous expression of ST6GALI, ST3GALIII, ST3GALI, and ST6GALNACI proteins; comparison of binding modes of 2aA–2eA, 3cB–3dB, 4cC–4dC, AL10, LCAG, and Lith-O-ASP in the binding sites of two asymmetric polypeptide chains (A/B) of ST6GALI (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QVT">6QVT</a>); computed physicochemical properties of the selected compounds used in this study; computational binding values of complex structure of ST6GALI-inhibitor; sensitization of tumors to ST inhibitors by regulation of the talin/integrin/FAK/paxillin and integrin/NFκB-signaling pathways; and experimental procedures, details of HPLC-determined purity data, HRMS results, and 1H and 13C NMR spectra of all final compounds and intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes

Caveolin‐1 Up‐regulates Integrin Α2,6‐sialylation to Promote Integrin Α5β1‐dependent Hepatocarcinoma Cell Adhesion

Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma

α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.

ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface

α2,6-Sialylation promotes hepatocellular carcinoma cells migration and invasion via enhancement of nSmase2-mediated exosomal miRNA sorting

ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation

Silencing of ST6GalNAc I Suppresses the Proliferation, Migration and Invasion of Hepatocarcinoma Cells Through PI3K/AKT/NF-κB Pathway

Α2,6-Hyposialylation of C-Met Abolishes Cell Motility of ST6Gal-I-knockdown HCT116 Cells

Knockdown of ST6Gal‐I Expression in Human Hepatocellular Carcinoma Cells Inhibits Their Exosome‐mediated Proliferation‐ and Migration‐promoting Effects

Caveolin-1 Up-Regulates ST6Gal-I to Promote the Adhesive Capability of Mouse Hepatocarcinoma Cells to Fibronectin Via FAK-mediated Adhesion Signaling.

The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation.

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth

Gal3ST-2 involved in tumor metastasis process by regulation of adhesion ability to selectins and expression of integrins.

Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis

Recent Advances in Understanding the Roles of Sialyltransferases in Tumor Angiogenesis and Metastasis.

Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation

Nucleotide Sugar Transporter SLC35A2 Is Involved In Promoting Metastatic Potential Of Hepatocellular Carcinoma

Role of Cell Surface Oligosaccharides of Mouse Mammary Tumor Cell Lines in Cancer Metastasis.

Identification and Analysis of Altered Alpha 1,6-Fucosylated Glycoproteins Associated with Hepatocellular Carcinoma Metastasis